- Latest week
- 10 Jul 2026
- Close
- 65.000000
- Fair value
- 66.208333
- Next-week expectancy
- Undecided 46.16%
IBT-B Chart Pack
Infant Bacterial Therapeutics AB (publ)
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, IBT-B rose 18.18%, moving from 55.00 to 65.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 8 of the last 12 weeks. Relative Strength is 5.96 and has improved across the 12-week window. Market Dynamics is 1.34 on the latest week. Next-week expectancy is undecided at 46.16% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 65.00
- 12-Week Change
- 18.18%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 46.16%
- Signal Weeks
- 8 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- 5.96
- Market Dynamics
- 1.34
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 65.00
- 12-Week Change
- 18.18%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 46.16%
- Signal Weeks
- 8 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- 5.96
- Market Dynamics
- 1.34
Over the latest 12 completed weeks ending 2026-07-10, IBT-B rose 18.18%, moving from 55.00 to 65.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 8 of the last 12 weeks. Relative Strength is 5.96 and has improved across the 12-week window. Market Dynamics is 1.34 on the latest week. Next-week expectancy is undecided at 46.16% based on similar historical setup states.
Industry Peers
Sweden equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| ALZ Alzinova AB (publ) | STO | 10 Jul 2026 | 0.51 | 1.61 | 0.48 | 0.70 | 38.61% |
| NXTCL NextCell Pharma AB | STO | 10 Jul 2026 | 0.95 | 1.25 | 0.92 | 1.18 | 24.42% |
| BIOSGN Biosergen AB (publ) | STO | 10 Jul 2026 | 5.10 | 6.70 | 5.10 | 6.25 | 22.55% |
| SYNACT SynAct Pharma AB | STO | 10 Jul 2026 | 18.88 | 23.50 | 17.90 | 21.80 | 15.47% |
| RESP Respiratorius AB | STO | 10 Jul 2026 | 2.92 | 3.42 | 2.61 | 3.25 | 11.30% |
| BIOVIC-B Biovica International AB (publ) | STO | 10 Jul 2026 | 0.37 | 0.44 | 0.36 | 0.41 | 10.27% |
| IRLAB-A IRLAB Therapeutics AB (publ) | STO | 10 Jul 2026 | 1.27 | 1.43 | 1.27 | 1.40 | 9.91% |
| IMMU Mendus AB (publ) | STO | 10 Jul 2026 | 6.21 | 7.24 | 6.06 | 6.82 | 9.82% |
| PILA Pila Pharma AB (publ) | STO | 10 Jul 2026 | 1.21 | 1.57 | 1.21 | 1.31 | 8.26% |
| FLUI Fluicell AB (publ) | STO | 10 Jul 2026 | 34.00 | 37.00 | 34.00 | 36.00 | 5.88% |
| CHOSA CHOSA Oncology AB | STO | 10 Jul 2026 | 0.75 | 0.80 | 0.74 | 0.79 | 5.87% |
| APTA Aptahem AB (publ) | STO | 10 Jul 2026 | 0.60 | 0.69 | 0.60 | 0.63 | 5.00% |
| EGTX Egetis Therapeutics AB (publ) | STO | 10 Jul 2026 | 5.84 | 6.30 | 5.63 | 6.08 | 4.11% |
| CLBIO Corline Biomedical AB | STO | 10 Jul 2026 | 17.00 | 18.35 | 16.50 | 17.45 | 2.65% |
| DMYD-B Diamyd Medical AB (publ) | STO | 10 Jul 2026 | 1.12 | 1.20 | 1.06 | 1.14 | 1.79% |
| ACOU AcouSort AB (publ) | STO | 10 Jul 2026 | 3.70 | 3.88 | 3.58 | 3.75 | 1.35% |